Equities

Hims & Hers Health Inc

Hims & Hers Health Inc

Actions
Health CareHealth Care Providers
  • Price (USD)29.82
  • Today's Change3.13 / 11.73%
  • Shares traded4.48m
  • 1 Year change+326.00%
  • Beta1.1467
Data delayed at least 15 minutes, as of Nov 13 2024 14:51 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.

  • Revenue in USD (TTM)1.24bn
  • Net income in USD101.26m
  • Incorporated2021
  • Employees1.05k
  • Location
    Hims & Hers Health Inc2269 Chestnut St, #523SAN FRANCISCO 94123United StatesUSA
  • Phone+1 (415) 851-0195
  • Fax+1 (302) 655-5049
  • Websitehttps://www.forhims.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Amedisys Inc2.32bn82.93m2.98bn19.00k36.162.6027.621.282.522.5270.4435.051.11--7.48122,161.103.977.825.3310.3943.6743.633.565.89--10.380.24140.000.5936.11-108.22--14.16--
PACS Group Inc-100.00bn-100.00bn3.19bn32.43k--5.47----------3.75----------------------------0.4792--28.47---25.00------
Brightspring Health Services Inc10.59bn-40.60m3.40bn35.00k--2.1121.600.3213-0.2623-0.262360.439.281.8821.1311.14302,520.40-0.765---0.9652--14.5017.75-0.4073-0.62890.97421.130.6247--14.3228.33-186.80--17.24--
Acadia Healthcare Company Inc3.12bn280.73m3.73bn23.50k13.131.218.541.193.053.0533.9933.040.5568--8.36183,677.905.182.326.102.64----9.315.601.065.090.3738--12.208.99-107.93--3.34--
Surgery Partners Inc2.99bn-60.60m3.76bn10.50k----14.711.26-0.4805-0.480523.69--------284,314.30--1.17--1.6326.5926.333.543.03--2.53----8.039.1478.21--17.41--
Option Care Health Inc4.78bn208.87m3.89bn5.81k19.122.7314.370.81421.191.1927.328.381.4313.4711.77822,202.406.263.637.914.3520.7622.454.372.781.327.060.4380.009.0643.4277.40--24.72--
Sotera Health Co1.12bn70.49m4.40bn3.00k62.669.3618.743.930.2480.2483.941.660.362310.977.36373,492.302.29-0.8682.44-0.966455.1654.406.31-2.682.612.200.8319--4.547.06121.87--24.24--
Select Medical Holdings Corp6.97bn265.80m5.06bn38.40k18.342.658.920.72542.142.1456.1014.780.8885--6.95181,472.604.524.195.635.4614.4213.985.095.11--4.530.578415.305.225.5753.0311.986.50--
Hims & Hers Health Inc1.24bn101.26m5.83bn1.05k61.7013.2150.724.700.43260.43265.452.022.446.59282.181,187,375.0019.93--25.93--81.13--8.15--1.82--0.00--65.49--64.15------
R1 Rcm Inc2.46bn-61.20m6.04bn29.40k--2.1523.932.45-0.1456-0.14565.746.660.4567--6.0283,799.32-1.131.35-1.221.5319.1920.09-2.481.96--1.240.4401--24.7921.02105.21--25.07--
CorVel Corp845.64m81.52m6.16bn4.87k76.4121.7856.307.284.704.7048.8016.501.78--8.93173,642.3017.1114.8729.4724.2121.8122.149.649.16----0.000.0010.685.9514.9010.5713.87--
Radnet Inc1.77bn-4.41m6.18bn7.87k--6.9137.443.49-0.0654-0.065424.8112.100.5946--8.41225,221.801.031.241.311.6620.6721.561.731.86--1.380.47660.0013.0510.64-71.42-37.6319.60--
Chemed Corp2.38bn301.73m8.47bn15.09k28.596.8323.253.5619.7819.78155.8282.781.43136.4913.04157,566.5018.1119.5321.7924.6435.6634.6012.6912.601.81--0.008.156.064.909.175.801.466.10
Ensign Group Inc4.11bn239.98m8.54bn35.30k36.094.8926.582.084.134.1370.8630.500.9433--8.01116,391.305.526.456.637.8821.1922.325.856.48----0.07736.5623.2716.28-6.8028.624.405.02
Data as of Nov 13 2024. Currency figures normalised to Hims & Hers Health Inc's reporting currency: US Dollar USD

Institutional shareholders

28.12%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202418.24m8.77%
BlackRock Fund Advisorsas of 30 Jun 202412.33m5.93%
Renaissance Technologies LLCas of 30 Jun 20246.04m2.90%
SSgA Funds Management, Inc.as of 30 Jun 20244.42m2.13%
Fidelity Management & Research Co. LLCas of 30 Jun 20243.84m1.85%
Geode Capital Management LLCas of 30 Jun 20243.81m1.83%
Dimensional Fund Advisors LPas of 30 Sep 20242.72m1.31%
Two Sigma Investments LPas of 30 Jun 20242.60m1.25%
Divisadero Street Capital Management LPas of 30 Jun 20242.28m1.10%
Wellington Management Co. LLPas of 30 Jun 20242.24m1.07%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.